R
RDS
Biotech & Life Sciences · Strasbourg, France · Founded 2020
Wearable remote monitoring for actionable clinical insights MoreLess
RDS is a healthcare technology startup that specializes in remote patient monitoring solutions. The company's primary product, MultiSense®, is designed to help healthcare professionals continuously monitor patients' physiological parameters, whether they're in a hospital or at home. This innovative and multi-patented technology is aimed at improving patient pathways, which in turn enhances the quality of life and care efficiencies.
The company's market is primarily hospitals (particularly surgical departments) and institutions that are looking for ways to improve patient care and reduce hospital stays. By facilitating early hospital discharge and continuous monitoring, RDS solution can contribute to significant healthcare savings.
The MultiSense® solution is now CE marked (MDR) and is available for sale in several European countries. The company generates recurring revenues by providing the solution on a “fee for a service” business model to healthcare institutions and professionals. The product has been well-received in the market, earning multiple awards and the support of a vibrant community of clinicians.
In addition to its primary product, RDS also provides services that help healthcare systems become more attractive and sustainable. This includes training and support for healthcare professionals to effectively use the MultiSense® technology.
Keywords: Healthcare Technology, Remote Patient Monitoring, MultiSense®, Patient Pathways, Care Efficiencies, Hospital Discharge, Healthcare Savings, Clinicians, Physiological Parameters, Sustainable Healthcare Systems.
Company overview
RDS company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Strasbourg, France
- Employees
- 152
- Open positions
- 1
- Dealroom signal
- 88.4
Valuation & funding
RDS funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2025 | $15M | $62M | Capital Grand Est · MACSF · Critical Path Ventures · Bpifrance | ↗ |
| SEED✓Equity / VC | Dec 2023 | $2.2M | $8.8M | Capital Grand Est · MACSF | ↗ |
| SEED✓Equity / VC | Aug 2023 | $3.3M | $13M | Undisclosed | — |
| SEED✓Equity / VC | Jan 2021 | $2.2M | $8.8M | Undisclosed | — |
| OtherOther financing | Feb 2020 | $1.1M | — | Sam Eletr · Elie Lobel · Institute of Image-Guided Surgery · IRCAD | — |
| SPINOUT✓Other financing | Jan 2020 | Institute of Image-Guided Surgery · University of Strasbourg | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 153 |
| 2025 | 133 |
Growth signals
RDS website traffic
Latest recorded traffic for RDS is 1.2K monthly website visits, down 47.8% over the last three months. RDS's team grew 14.3% over the past year.
Hiring
Open positions at RDS
Current openings linked to this company in Dealroom.
Comparisons
RDS compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
RDS's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where RDS has talent and traffic
team presence
In the news
Latest news about RDS
Recent press, funding announcements, and product moves mentioning RDS — open to read from the original sources.
Market sentiment
What the market is saying about RDS
An AI-synthesized read of the highest-engagement posts about RDS on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RDS’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.


















